Status:
RECRUITING
Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination
Lead Sponsor:
University of Bergen
Collaborating Sponsors:
Haukeland University Hospital
Conditions:
Covid19
Eligibility:
All Genders
20-100 years
Brief Summary
The ongoing Coronavirus Disease 2019 (COVID-19) pandemic has been intensified by no population-based immunity to the severe acute respiratory disease coronavirus 2 (SARS-CoV2) and initially lack of ef...
Detailed Description
The primary aim of this study is * To compare immune responses after natural SARS-CoV-2 infection and COVID-19 vaccination The secondary aims are * To compare the duration and breadth of antibody res...
Eligibility Criteria
Inclusion
- subjects prioritized by national vaccination program
Exclusion
- Children
- unable or unwilling to provide informed consent
Key Trial Info
Start Date :
January 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 12 2030
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04706390
Start Date
January 12 2021
End Date
December 12 2030
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bergen
Bergen, Norway, 5020